Autonomix Medical (AMIX) Shares Outstanding (Weighted Average) (2022 - 2025)

Autonomix Medical (AMIX) has 4 years of Shares Outstanding (Weighted Average) data on file, last reported at $9.0 million in Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $9.0 million, up 522.8% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.0 million (up 522.8% YoY), and the FY2025 annual result was $25003.0, down 97.6% from the prior year.
• Shares Outstanding (Weighted Average) improved to $9.0 million in Q4 2025 per AMIX's latest filing, from $4.3 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $12.9 million in Q2 2023 and troughed at $25003.0 in Q1 2025.
• A 4-year average of $4.0 million and a median of $1.3 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• On a YoY basis, Shares Outstanding (Weighted Average) climbed as much as 522.8% in 2025 and fell as far as 97.6% in 2025.
• A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $12.0 million in 2022, then slumped by 91.67% to $999866.0 in 2023, then surged by 43.82% to $1.4 million in 2024, then surged by 522.8% to $9.0 million in 2025.
• Business Quant data shows AMIX's Shares Outstanding (Weighted Average) at $9.0 million in Q4 2025, $4.3 million in Q3 2025, and $3.1 million in Q2 2025.